Influence of CYP3A5 Polymorphism on Liver Function Abnormality and the Trough Level Change After Conversion
Status:
Unknown status
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
This study is a multicenter, single-arm, open-label, 24 weeks, and investigator-initiated
clinical trial to assess the influence of CYP3A5 polymorphism on liver function abnormality
and the trough level change after conversion to Advagraf® in liver transplant recipients.